ADVIRNA

advirna-logo

Advirna is a private biotechnology company developing innovative solutions for efficient delivery of polynucleotides in vivo. Advirna’s self-deliverable RNAi is based on the recent breakthrough in biology known as RNA interference (RNAi). This discovery opened a possibility to specifically regulate activity of genes inside a living cell.

#SimilarOrganizations #People #Financial #Website #More

ADVIRNA

Industry:
Biotechnology

Founded:
2008-01-01

Address:
Worcester, Massachusetts, United States

Country:
United States

Website Url:
http://www.advirna.com

Total Employee:
1+

Status:
Active

Contact:
+1 720-440-2184

Total Funding:
150 K USD

Technology used in webpage:
Font Awesome Pound Sterling Lorem Ipsum Squarespace Hosted Unified Layer


Similar Organizations

epitomics-logo

Epitomics

An Emerging Biotechnology Company

genosco-logo

Genosco

Genosco is a biotechnology company.

novomedix-logo

NovoMedix

NovoMedix is a Biotechnology Company.

xeophin-logo

Xeophin

Xeophin is a Biotechnology Company.


Current Advisors List

taisia-shmushkovich_image

Taisia Shmushkovich Principal Scientist @ Advirna
Advisor
2017-01-01

Current Employees Featured

alexey-wolfson_image

Alexey Wolfson
Alexey Wolfson CEO @ Advirna
CEO
2010-01-01

Investors List

national-science-foundation_image

National Science Foundation

National Science Foundation investment in Grant - Advirna

Official Site Inspections

http://www.advirna.com

  • Host name: 198.185.159.144
  • IP address: 198.185.159.144
  • Location: New York United States
  • Latitude: 40.7157
  • Longitude: -74
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 10013

Loading ...

More informations about "Advirna"

Advirna - Crunchbase Company Profile & Funding

Advirna is a private biotechnology company developing innovative solutions for efficient delivery of polynucleotides in vivo. Advirna’s self-deliverable RNAi is …See details»

Our Team - ADViRNA

ADViRNA was founded in 2007 by Anastasia Khvorova, PhD and Alexey Wolfson, PhD. Their mission was to make a new nucleic based technology for therapeutic research use. They …See details»

Advirna Company Profile 2024: Valuation, Funding & Investors

Advirna General Information Description. Developer of self-deliverable RNAi technology designed for oligonucleotide delivery to cells for gene knockdown. The company's technology allows …See details»

Contact Us - ADViRNA

ADViRNA, LLC. [email protected] 508-762-9133. 17 Briden Street Worcester, MA 01605. Name * First Name. Last Name. Email * Company/Institution * Message * Thank you! sdRNA …See details»

ADViRNA - LinkedIn

Advirna is a private biotechnology company at the forefront of developing innovative solutions for the efficient delivery of polynucleotides. Our proprietary technology platform, self-deliverable ...See details»

Advirna - Overview, News & Similar companies | ZoomInfo.com

Who is Advirna. Advirna is developing innovative solutions for oligonucleotide delivery to cells ex-vivo and in-vivo. Our technology platform - self-deliverable RN Ai technology (sdRNAi) allows …See details»

Advirna Company Profile - Office Locations, Competitors ... - Craft

Advirna is a company that develops solutions for the delivery of polynucleotides in vivo. Its platform, self-deliverable RNAi, is based on RNA interference (RNAi). Advirna's technology is …See details»

Advirna Genomics, Inc. Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Advirna Genomics, Inc. of Westborough, MA. Get the latest business insights from Dun & Bradstreet.See details»

Advirna, LLC Company Profile | Worcester, MA - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Advirna, LLC of Worcester, MA. Get the latest business insights from Dun & Bradstreet.See details»

Advirna - Company Profile - Tracxn

Oct 20, 2024 Advirna - Developer of technology for ex-vivo and in-vivo oligonucleotide delivery. Raised funding over 1 round from 2 investors. Founded by Alexey Wolfson in the year 2008. …See details»

Advirna: Contact Details and Business Profile - RocketReach

Advirna is a private biotechnology company developing innovative solutions for efficient delivery of polynucleotides in vivo. Our technology platform, self-deliverable RNAi, is based on the recent …See details»

Advirna - The Org

Advirna is a Biotechnology Company. Advirna is a Biotechnology Company. Platform. Features. Pricing. Log in Sign up. Advirna. 1 follower ...See details»

AdviRNA LLC | www.inknowvation.com

Formerly known as Advanced RNA Technologies LLC, Advirna LLC is a biotechnology company developing solutions for efficient delivery of polynucleotides in vivo. The firm recently (Spring …See details»

Advirna - Company Profile & Staff Directory - ContactOut

Advirna is a private biotechnology company developing innovative solutions for efficient delivery of polynucleotides in vivo. Our technology platform, self-deliverable RNAi, is based on the recent …See details»

Advirna - Contacts, Employees, Board Members, Advisors & Alumni

Organization. Advirna . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... About. Advirna has 1 current employee profile, CEO …See details»

ADViRNA siRNA sdRNA Technology — ADViRNA

Alexey Wolfson, CEO of Advirna Oncology pitches at The Venture Forum's 5 Minute Pitch Contest. sdRNA reagents are available for Research Use Only and sales are subject to Terms …See details»

Advirna - Company Info, Employees & Competitors

View Advirna advirna.com location in 60 prescott st, worcester, massachusetts, 01605, united states, revenue, industry and description. Find related and similar companies as well as …See details»

Advirna: Revenue, Competitors, Alternatives - Growjo

Advirna is a private biotechnology company developing innovative solutions for efficient delivery of polynucleotides in vivo. Our technology platform, self-deliverable RNAi, is based on the recent …See details»

ADViRNA Services — ADViRNA

Innovative solutions for delivery of polynucleotides in vivo and ex vivo for self-delivery of RNAi therapeutics. Develop, validate and provide fully modified sdRNA oligonucleotides for specific …See details»

linkstock.net © 2022. All rights reserved